KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Interest Expenses (2020 - 2024)

Ginkgo Bioworks Holdings (DNA) has disclosed Interest Expenses for 3 consecutive years, with -$15.0 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Interest Expenses changed N/A year-over-year to -$15.0 million, compared with a TTM value of -$29.4 million through Dec 2023, changed N/A, and an annual FY2024 reading of $94000.0, up 1.08% over the prior year.
  • Interest Expenses was -$15.0 million for Q3 2023 at Ginkgo Bioworks Holdings, down from -$14.3 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $590000.0 in Q4 2020 and bottomed at -$15.0 million in Q3 2023.
  • Average Interest Expenses over 3 years is -$7.1 million, with a median of -$6.9 million recorded in 2021.
  • Peak annual rise in Interest Expenses hit 6.61% in 2021, while the deepest fall reached 6.61% in 2021.
  • Year by year, Interest Expenses stood at $590000.0 in 2020, then dropped by 6.61% to $551000.0 in 2021, then plummeted by 2825.95% to -$15.0 million in 2023.
  • Business Quant data shows Interest Expenses for DNA at -$15.0 million in Q3 2023, -$14.3 million in Q2 2023, and $551000.0 in Q4 2021.